Indeed, HGF expression was correlated with innate resistance to BRAF inhibition, and increased HGF plasma levels predicted worse overall survival (OS) and progression-free survival (PFS) in BRAF-mutant melanoma patients (Straussman et al., 2012; Wilson et al., 2012). This evidence concerns the gene BRAF and melanoma.